24 April 2024

NICE approval of combination treatment for paediatric brain tumour

Novartis announced today that the National Institute for Health and Care Excellence (NICE) has published its Final Draft Guidance NICE has recommended the combination therapy of dabrafenib (Finlee®) and trametinib (Spexotras®) for the treatment of children with low-grade glioma (LGG)…

Read

30 June 2023

Connecting worldwide at the IBTA Summit

Brain Tumour Support Services Manager, Lucy Wilkinson, looks back on IBTA Summit.

Read